Instil Bio, Inc. (TIL)

Instil Bio Statistics

Total Valuation

Instil Bio has a market cap or net worth of $54.93 million. The enterprise value is $63.85 million.

Market Cap	54.93M
Enterprise Value	63.85M

Important Dates

The last earnings date was Friday, May 15, 2026, before market open.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.78 million shares outstanding. The number of shares has increased by 3.27% in one year.

Current Share Class	6.78M
Shares Outstanding	6.78M
Shares Change (YoY)	+3.27%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.02%
Owned by Institutions (%)	18.13%
Float	3.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.48
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.75
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.07

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-12.90%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	9.40%
Revenue Per Employee	n/a
Profits Per Employee	-$2.79M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.09% in the last 52 weeks. The beta is 1.95, so Instil Bio's price volatility has been higher than the market average.

Beta (5Y)	1.95
52-Week Price Change	-70.09%
50-Day Moving Average	8.21
200-Day Moving Average	12.95
Relative Strength Index (RSI)	46.82
Average Volume (20 Days)	34,603

Short Selling Information

The latest short interest is 231,366, so 3.41% of the outstanding shares have been sold short.

Short Interest	231,366
Short Previous Month	260,419
Short % of Shares Out	3.41%
Short % of Float	6.39%
Short Ratio (days to cover)	9.12

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-44.45M
Pretax Income	-47.38M
Net Income	-47.38M
EBITDA	-44.28M
EBIT	-44.45M
Earnings Per Share (EPS)	-$7.04

Balance Sheet

The company has $76.13 million in cash and $85.18 million in debt, with a net cash position of -$9.05 million or -$1.33 per share.

Cash & Cash Equivalents	76.13M
Total Debt	85.18M
Net Cash	-9.05M
Net Cash Per Share	-$1.33
Equity (Book Value)	113.87M
Book Value Per Share	16.79
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	169,500
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.27%
Shareholder Yield	-3.27%
Earnings Yield	-86.46%
FCF Yield	n/a

Analyst Forecast

The average price target for Instil Bio is $7.00, which is -13.58% lower than the current price. The consensus rating is "Hold".

Price Target	$7.00
Price Target Difference	-13.58%
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a